Phase 3 Clinical Study of Mazdutide in Chinese Adults with Overweight or Obesity (GLORY-1) Published in The New England Journal of Medicine (NEJM)

Phase 3 Clinical Study of Mazdutide in Chinese Adults with Overweight or Obesity (GLORY-1) Published in The New England Journal of Medicine (NEJM)

SAN FRANCISCO and SUZHOU, China, May 26, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of...

EDAN Highlights Commitment to Global Health at GHF 2025 Satellite Symposium, a Side Event of the World Health Assembly

EDAN Highlights Commitment to Global Health at GHF 2025 Satellite Symposium, a Side Event of the World Health Assembly

GENEVA, May 25, 2025 /PRNewswire/ -- Edan Instruments, Inc. (300206.SZ), a leading global medical device company, participated in the Geneva Health Forum (GHF) 2025 Satellite Symposium, held as a side event of the World Health Assembly (WHA). Titled...

Systems Spray-Cooled New Investment and Partnership for Global Growth

Systems Spray-Cooled New Investment and Partnership for Global Growth

NASHVILLE, Tenn. , May 21, 2025 /PRNewswire/ -- We are excited to announce that The Systems Group has brought on a new investor into the Systems Spray-Cooled (SSC) business unit. David Brogdon is one of the founders of Bad Boy Mowers and he, along...

Baidu Announces First Quarter 2025 Results

Baidu Announces First Quarter 2025 Results

BEIJING, May 21, 2025 /PRNewswire/ -- Baidu, Inc. (NASDAQ: BIDU and HKEX: 9888 (HKD Counter) and 89888 (RMB Counter)) ("Baidu" or the "Company"), a leading AI company with a strong Internet foundation, today announced its unaudited financial results...

ZTO Reports First Quarter 2025 Unaudited Financial Results

ZTO Reports First Quarter 2025 Unaudited Financial Results

Parcels Volume Increased 19.1% to 8.5 Billion Adjusted Net Income Grew 1.6 % to RMB2.3 Billion Annual Volume Guidance Reiterated to Grow 20%-24% SHANGHAI, May 21, 2025 /PRNewswire/ -- ZTO Express (Cayman) Inc. (NYSE: ZTO and SEHK: 2057), a leading...

PeproMene Bio, Inc. and the Institute for Follicular Lymphoma Innovation (IFLI) Announce The First Follicular Lymphoma (FL) Patient Treated with BAFF-R Targeting CAR-T Cells (PMB-CT01) Achieves a Complete Response

PeproMene Bio, Inc. and the Institute for Follicular Lymphoma Innovation (IFLI) Announce The First Follicular Lymphoma (FL) Patient Treated with BAFF-R Targeting CAR-T Cells (PMB-CT01) Achieves a Complete Response

The first heavily pretreated r/r FL patient dosed at City of Hope with PMB-CT01 achieved a CR at one-month post treatment. A Total of 7/7 r/r B-NHL patients including MCL, DLBCL and FL treated with PMB-CT01 have achieved a sustained CR (1 to 29+...

NYSE Content Advisory: Pre-Market update + Home Depot reaffirms full-year outlook

NYSE Content Advisory: Pre-Market update + Home Depot reaffirms full-year outlook

NEW YORK, May 20, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins. Kristen Scholer...

NYSE Content Advisory: Pre-Market update

NYSE Content Advisory: Pre-Market update

NEW YORK, May 19, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins. Kristen Scholer...

Microvast at CIBF 2025: Powering What's Next

Microvast at CIBF 2025: Powering What's Next

STAFFORD, Texas, May 19, 2025 /PRNewswire/ -- Microvast Holdings, Inc. (NASDAQ: MVST) ("Microvast" or the "Company"), a global leader in advanced battery technologies, has highlighted its comprehensive suite of high-performance battery products at...

Innovent Released 2024 ESG Report, Underscoring Commitment to Sustainable Development and Global Innovation

Innovent Released 2024 ESG Report, Underscoring Commitment to Sustainable Development and Global Innovation

SAN FRANCISCO and SUZHOU, China, May 19, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of...

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • ...
  • 34
  • menu
    menu